Additionally, this class of medications may be used to treat benign prostatic hyperplasia
Naunyn Schmiedebergs Arch Pharmacol 398:15451556
Furthermore, a prespecified subgroup analysis of HF individuals from the SELECT trial evaluating the effects of semaglutide on cardiovascular outcomes in people with overweight or obesity, which included 2,273 HFpEF and 1,347 HFrEF patients, showed that the therapy was associated with a reduction in the HF composite outcome (cardiovascular death or HF hospitalisation/emergency visit) across LVEF, suggesting that GLP-1 RAs may improve outcomes at least in obese HF patients regardless of diabetes status
The broader evidence base for over-the-counter weight loss supplements is generally weak most studies are small, short-term, and often industry-funded, and systematic reviews consistently find limited or inconclusive results
Po upywie miesica dawk mona zwikszy do 7 mg